Patron Member

Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options. Our focus is on improving the lives of patients by pushing the boundaries of research and development and ensuring access to ground-breaking therapies.  Courage, passion, collaboration with partners and our entrepreneurial spirit are key in our efforts to release the full value of medical innovations for patients and society.